MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$23,031K
Net Income
-$9,413K
Net Profit Margin
-40.87%
EPS
-$0.07
Unit: Thousand (K) dollars
Revenue Breakdown
    • Orthobiologics
    • Spinal Implant
Revenue Breakdown
    • orthobiologics-orthobiologics-Or...
    • spinal implant-spinal implant-Sp...
Revenue Breakdown
    • us-us-US
    • non us-non us-Non Us
Revenue Breakdown
    • gross profit
    • cost of sales
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
total revenue
23,031
20,884
32,357
33,255
Cost of sales
9,701
8,913
14,603
11,263
Gross profit
13,330
11,971
17,754
21,992
General and administrative
6,436
6,273
7,293
7,071
Sales and marketing
10,368
8,186
10,946
11,746
Research and development
695
435
459
634
Write-off of distribution agreement deposit
5,000
-
-
-
Total operating expenses
22,499
14,894
18,698
19,451
(gain) income from operations
-9,169
-2,923
-944
2,541
Interest expense
542
599
718
904
Interest income
1
219
24*
-
Unrealized foreign currency translation gain
23
-1
-206
-56
Gain on divestiture
-
-
3,352*
-
Other income (expense)
347
242
91
-16
Total other expense
-171
-139
2,542
-976
Net (loss) income from operations before provision for income taxes
-9,340
-3,062
1,598
1,565
Provision for income taxes current and deferred
73
27
1,541
257
Net (loss) income
-9,413
-3,089
57
1,308
Basic EPS
-0.07
-0.02
0
0.01
Diluted EPS
-0.07
-0.02
0
0.01
Basic Average Shares
140,258,667
140,058,787
140,034,775
139,712,969
Diluted Average Shares
140,258,667
140,058,787
157,883,634
150,377,234
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Orthobiologics$17,360K (-10.38%↓ Y/Y)Spinal Implant$5,671K (-48.75%↓ Y/Y)Net (loss) income-$9,413K (-365.15%↓ Y/Y)product-product-Product$23,031K Net (loss) incomefrom operations...-$9,340K (-345.47%↓ Y/Y)Provision for income taxescurrent and deferred$73K (-71.37%↓ Y/Y)total revenue$23,031K (-34.96%↓ Y/Y)(gain) income fromoperations-$9,169K (-298.29%↓ Y/Y)Total other expense-$171K (79.12%↑ Y/Y)Gross profit$13,330K (-45.11%↓ Y/Y)Other income(expense)$347K (4857.14%↑ Y/Y)Unrealized foreigncurrency translation...$23K (-87.08%↓ Y/Y)Interest income$1K Cost of sales$9,701K (-12.82%↓ Y/Y)Total operatingexpenses$22,499K (14.44%↑ Y/Y)Interest expense$542K (-46.02%↓ Y/Y)Sales and marketing$10,368K (-10.74%↓ Y/Y)General andadministrative$6,436K (-13.93%↓ Y/Y)Write-off of distributionagreement deposit$5,000K Research and development$695K (22.79%↑ Y/Y)

Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical Holdings, Inc. (XTNT)